The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mycobacterium Tuberculosis Market Research Report 2025
Synopsis
The global Mycobacterium Tuberculosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mycobacterium Tuberculosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycobacterium Tuberculosis.
Report Scope
The Mycobacterium Tuberculosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mycobacterium Tuberculosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycobacterium Tuberculosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Merck
Sanofi
Thermo Fisher Scientific
Danaher
Roche
Novartis
Segment by Type
Real-time Inspection
Nucleic Acid Amplification Test
Skin Test for Tuberculosis
Other
Segment by Application
Hospital
Specialist Clinic
Diagnostic Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycobacterium Tuberculosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Mycobacterium Tuberculosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mycobacterium Tuberculosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycobacterium Tuberculosis.
Report Scope
The Mycobacterium Tuberculosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mycobacterium Tuberculosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycobacterium Tuberculosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Merck
Sanofi
Thermo Fisher Scientific
Danaher
Roche
Novartis
Segment by Type
Real-time Inspection
Nucleic Acid Amplification Test
Skin Test for Tuberculosis
Other
Segment by Application
Hospital
Specialist Clinic
Diagnostic Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycobacterium Tuberculosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mycobacterium Tuberculosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Real-time Inspection
1.2.3 Nucleic Acid Amplification Test
1.2.4 Skin Test for Tuberculosis
1.2.5 Other
1.3 Market by Application
1.3.1 Global Mycobacterium Tuberculosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Diagnostic Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mycobacterium Tuberculosis Market Perspective (2019-2030)
2.2 Mycobacterium Tuberculosis Growth Trends by Region
2.2.1 Global Mycobacterium Tuberculosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mycobacterium Tuberculosis Historic Market Size by Region (2019-2024)
2.2.3 Mycobacterium Tuberculosis Forecasted Market Size by Region (2025-2030)
2.3 Mycobacterium Tuberculosis Market Dynamics
2.3.1 Mycobacterium Tuberculosis Industry Trends
2.3.2 Mycobacterium Tuberculosis Market Drivers
2.3.3 Mycobacterium Tuberculosis Market Challenges
2.3.4 Mycobacterium Tuberculosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mycobacterium Tuberculosis Players by Revenue
3.1.1 Global Top Mycobacterium Tuberculosis Players by Revenue (2019-2024)
3.1.2 Global Mycobacterium Tuberculosis Revenue Market Share by Players (2019-2024)
3.2 Global Mycobacterium Tuberculosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mycobacterium Tuberculosis Revenue
3.4 Global Mycobacterium Tuberculosis Market Concentration Ratio
3.4.1 Global Mycobacterium Tuberculosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mycobacterium Tuberculosis Revenue in 2023
3.5 Mycobacterium Tuberculosis Key Players Head office and Area Served
3.6 Key Players Mycobacterium Tuberculosis Product Solution and Service
3.7 Date of Enter into Mycobacterium Tuberculosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mycobacterium Tuberculosis Breakdown Data by Type
4.1 Global Mycobacterium Tuberculosis Historic Market Size by Type (2019-2024)
4.2 Global Mycobacterium Tuberculosis Forecasted Market Size by Type (2025-2030)
5 Mycobacterium Tuberculosis Breakdown Data by Application
5.1 Global Mycobacterium Tuberculosis Historic Market Size by Application (2019-2024)
5.2 Global Mycobacterium Tuberculosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mycobacterium Tuberculosis Market Size (2019-2030)
6.2 North America Mycobacterium Tuberculosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Mycobacterium Tuberculosis Market Size by Country (2019-2024)
6.4 North America Mycobacterium Tuberculosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mycobacterium Tuberculosis Market Size (2019-2030)
7.2 Europe Mycobacterium Tuberculosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Mycobacterium Tuberculosis Market Size by Country (2019-2024)
7.4 Europe Mycobacterium Tuberculosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mycobacterium Tuberculosis Market Size (2019-2030)
8.2 Asia-Pacific Mycobacterium Tuberculosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Mycobacterium Tuberculosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Mycobacterium Tuberculosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mycobacterium Tuberculosis Market Size (2019-2030)
9.2 Latin America Mycobacterium Tuberculosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Mycobacterium Tuberculosis Market Size by Country (2019-2024)
9.4 Latin America Mycobacterium Tuberculosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mycobacterium Tuberculosis Market Size (2019-2030)
10.2 Middle East & Africa Mycobacterium Tuberculosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Mycobacterium Tuberculosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Mycobacterium Tuberculosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lupin
11.1.1 Lupin Company Detail
11.1.2 Lupin Business Overview
11.1.3 Lupin Mycobacterium Tuberculosis Introduction
11.1.4 Lupin Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.1.5 Lupin Recent Development
11.2 Macleods Pharmaceuticals
11.2.1 Macleods Pharmaceuticals Company Detail
11.2.2 Macleods Pharmaceuticals Business Overview
11.2.3 Macleods Pharmaceuticals Mycobacterium Tuberculosis Introduction
11.2.4 Macleods Pharmaceuticals Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.2.5 Macleods Pharmaceuticals Recent Development
11.3 Otsuka Pharmaceutical
11.3.1 Otsuka Pharmaceutical Company Detail
11.3.2 Otsuka Pharmaceutical Business Overview
11.3.3 Otsuka Pharmaceutical Mycobacterium Tuberculosis Introduction
11.3.4 Otsuka Pharmaceutical Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.3.5 Otsuka Pharmaceutical Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Mycobacterium Tuberculosis Introduction
11.4.4 Johnson & Johnson Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Mycobacterium Tuberculosis Introduction
11.5.4 Pfizer Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Mycobacterium Tuberculosis Introduction
11.6.4 Novartis Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Mycobacterium Tuberculosis Introduction
11.7.4 Abbott Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.7.5 Abbott Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Mycobacterium Tuberculosis Introduction
11.8.4 AstraZeneca Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Mycobacterium Tuberculosis Introduction
11.9.4 Bayer Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Mycobacterium Tuberculosis Introduction
11.10.4 Merck Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.10.5 Merck Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Mycobacterium Tuberculosis Introduction
11.11.4 Sanofi Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.11.5 Sanofi Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Mycobacterium Tuberculosis Introduction
11.12.4 Thermo Fisher Scientific Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Danaher
11.13.1 Danaher Company Detail
11.13.2 Danaher Business Overview
11.13.3 Danaher Mycobacterium Tuberculosis Introduction
11.13.4 Danaher Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.13.5 Danaher Recent Development
11.14 Roche
11.14.1 Roche Company Detail
11.14.2 Roche Business Overview
11.14.3 Roche Mycobacterium Tuberculosis Introduction
11.14.4 Roche Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.14.5 Roche Recent Development
11.15 Novartis
11.15.1 Novartis Company Detail
11.15.2 Novartis Business Overview
11.15.3 Novartis Mycobacterium Tuberculosis Introduction
11.15.4 Novartis Revenue in Mycobacterium Tuberculosis Business (2019-2024)
11.15.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Mycobacterium Tuberculosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Real-time Inspection
Table 3. Key Players of Nucleic Acid Amplification Test
Table 4. Key Players of Skin Test for Tuberculosis
Table 5. Key Players of Other
Table 6. Global Mycobacterium Tuberculosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Mycobacterium Tuberculosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Mycobacterium Tuberculosis Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Mycobacterium Tuberculosis Market Share by Region (2019-2024)
Table 10. Global Mycobacterium Tuberculosis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Mycobacterium Tuberculosis Market Share by Region (2025-2030)
Table 12. Mycobacterium Tuberculosis Market Trends
Table 13. Mycobacterium Tuberculosis Market Drivers
Table 14. Mycobacterium Tuberculosis Market Challenges
Table 15. Mycobacterium Tuberculosis Market Restraints
Table 16. Global Mycobacterium Tuberculosis Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Mycobacterium Tuberculosis Market Share by Players (2019-2024)
Table 18. Global Top Mycobacterium Tuberculosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycobacterium Tuberculosis as of 2023)
Table 19. Ranking of Global Top Mycobacterium Tuberculosis Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Mycobacterium Tuberculosis Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Mycobacterium Tuberculosis Product Solution and Service
Table 23. Date of Enter into Mycobacterium Tuberculosis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mycobacterium Tuberculosis Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Mycobacterium Tuberculosis Revenue Market Share by Type (2019-2024)
Table 27. Global Mycobacterium Tuberculosis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Mycobacterium Tuberculosis Revenue Market Share by Type (2025-2030)
Table 29. Global Mycobacterium Tuberculosis Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Mycobacterium Tuberculosis Revenue Market Share by Application (2019-2024)
Table 31. Global Mycobacterium Tuberculosis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Mycobacterium Tuberculosis Revenue Market Share by Application (2025-2030)
Table 33. North America Mycobacterium Tuberculosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Mycobacterium Tuberculosis Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Mycobacterium Tuberculosis Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Mycobacterium Tuberculosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Mycobacterium Tuberculosis Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Mycobacterium Tuberculosis Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Mycobacterium Tuberculosis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Mycobacterium Tuberculosis Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Mycobacterium Tuberculosis Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Mycobacterium Tuberculosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Mycobacterium Tuberculosis Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Mycobacterium Tuberculosis Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Mycobacterium Tuberculosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Mycobacterium Tuberculosis Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Mycobacterium Tuberculosis Market Size by Country (2025-2030) & (US$ Million)
Table 48. Lupin Company Detail
Table 49. Lupin Business Overview
Table 50. Lupin Mycobacterium Tuberculosis Product
Table 51. Lupin Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 52. Lupin Recent Development
Table 53. Macleods Pharmaceuticals Company Detail
Table 54. Macleods Pharmaceuticals Business Overview
Table 55. Macleods Pharmaceuticals Mycobacterium Tuberculosis Product
Table 56. Macleods Pharmaceuticals Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 57. Macleods Pharmaceuticals Recent Development
Table 58. Otsuka Pharmaceutical Company Detail
Table 59. Otsuka Pharmaceutical Business Overview
Table 60. Otsuka Pharmaceutical Mycobacterium Tuberculosis Product
Table 61. Otsuka Pharmaceutical Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 62. Otsuka Pharmaceutical Recent Development
Table 63. Johnson & Johnson Company Detail
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Mycobacterium Tuberculosis Product
Table 66. Johnson & Johnson Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Mycobacterium Tuberculosis Product
Table 71. Pfizer Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Novartis Company Detail
Table 74. Novartis Business Overview
Table 75. Novartis Mycobacterium Tuberculosis Product
Table 76. Novartis Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Abbott Company Detail
Table 79. Abbott Business Overview
Table 80. Abbott Mycobacterium Tuberculosis Product
Table 81. Abbott Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 82. Abbott Recent Development
Table 83. AstraZeneca Company Detail
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Mycobacterium Tuberculosis Product
Table 86. AstraZeneca Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 87. AstraZeneca Recent Development
Table 88. Bayer Company Detail
Table 89. Bayer Business Overview
Table 90. Bayer Mycobacterium Tuberculosis Product
Table 91. Bayer Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 92. Bayer Recent Development
Table 93. Merck Company Detail
Table 94. Merck Business Overview
Table 95. Merck Mycobacterium Tuberculosis Product
Table 96. Merck Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 97. Merck Recent Development
Table 98. Sanofi Company Detail
Table 99. Sanofi Business Overview
Table 100. Sanofi Mycobacterium Tuberculosis Product
Table 101. Sanofi Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 102. Sanofi Recent Development
Table 103. Thermo Fisher Scientific Company Detail
Table 104. Thermo Fisher Scientific Business Overview
Table 105. Thermo Fisher Scientific Mycobacterium Tuberculosis Product
Table 106. Thermo Fisher Scientific Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 107. Thermo Fisher Scientific Recent Development
Table 108. Danaher Company Detail
Table 109. Danaher Business Overview
Table 110. Danaher Mycobacterium Tuberculosis Product
Table 111. Danaher Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 112. Danaher Recent Development
Table 113. Roche Company Detail
Table 114. Roche Business Overview
Table 115. Roche Mycobacterium Tuberculosis Product
Table 116. Roche Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 117. Roche Recent Development
Table 118. Novartis Company Detail
Table 119. Novartis Business Overview
Table 120. Novartis Mycobacterium Tuberculosis Product
Table 121. Novartis Revenue in Mycobacterium Tuberculosis Business (2019-2024) & (US$ Million)
Table 122. Novartis Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mycobacterium Tuberculosis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Mycobacterium Tuberculosis Market Share by Type: 2023 VS 2030
Figure 3. Real-time Inspection Features
Figure 4. Nucleic Acid Amplification Test Features
Figure 5. Skin Test for Tuberculosis Features
Figure 6. Other Features
Figure 7. Global Mycobacterium Tuberculosis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Mycobacterium Tuberculosis Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Specialist Clinic Case Studies
Figure 11. Diagnostic Laboratory Case Studies
Figure 12. Mycobacterium Tuberculosis Report Years Considered
Figure 13. Global Mycobacterium Tuberculosis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Mycobacterium Tuberculosis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Mycobacterium Tuberculosis Market Share by Region: 2023 VS 2030
Figure 16. Global Mycobacterium Tuberculosis Market Share by Players in 2023
Figure 17. Global Top Mycobacterium Tuberculosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycobacterium Tuberculosis as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Mycobacterium Tuberculosis Revenue in 2023
Figure 19. North America Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Mycobacterium Tuberculosis Market Share by Country (2019-2030)
Figure 21. United States Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Mycobacterium Tuberculosis Market Share by Country (2019-2030)
Figure 25. Germany Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Mycobacterium Tuberculosis Market Share by Region (2019-2030)
Figure 33. China Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Mycobacterium Tuberculosis Market Share by Country (2019-2030)
Figure 41. Mexico Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Mycobacterium Tuberculosis Market Share by Country (2019-2030)
Figure 45. Turkey Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Mycobacterium Tuberculosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Lupin Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 48. Macleods Pharmaceuticals Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 49. Otsuka Pharmaceutical Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 50. Johnson & Johnson Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 51. Pfizer Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 53. Abbott Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 54. AstraZeneca Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 55. Bayer Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 57. Sanofi Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 59. Danaher Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 60. Roche Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 61. Novartis Revenue Growth Rate in Mycobacterium Tuberculosis Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
